OpenAI acquires Orchestra Bio
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Story
OpenAI · Artificial Intelligence
Join the conversation
Discuss the story with the TraceFeed community.
No comments yet. Be the first to add a perspective.